Effects of liposome-entrapped annamycin in human breast cancer cells

Interference with cell cycle progression and induction of apoptosis

Linda Orlandi, Gloria Bertoli, Gabriella Abolafio, Maria Grazia Daidone, Nadia Zaffaroni

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The effects of liposome-encapsulated annamycin (L-Ann) were investigated in two human breast cancer cell lines, MCF7 and MDA-MB-435. For comparative purposes, doxorubicin (Dx) was used throughout the study. A 4-hour treatment with L-Ann was significantly more active in MDA-MB-435 than in MCF7 cells (IC50 values of 0.03 and 0.08 μg/ml, respectively), whereas Dx was equally active in the two cell lines (IC50 0.12 μg/ml). L-Ann induced an accumulation of cells in G2M phases which was dose-dependent in MDA-MB-435 but not in MCF7 cells. Dx also caused a dose-dependent increase of G2M cell fraction in MDA-MB-435 cells, whereas a G2M cell accumulation was observed only after treatment with the highest Dx concentration in MCF7 cells. G2M phase cell accumulations induced in MCF7 cells by L-Ann or Dx were accompanied by a decrease in cdc2 kinase activity and in cyclin B1 and cdc2 expression. Conversely, in MDA-MB-435 cells exposed to L-Ann or Dx, cdc2 kinase activity, cyclin B1 and cdc2 expression increased in parallel to the increase in the number of cells accumulated in the G2M phase. L-Ann and Dx induced apoptosis in MDA-MB-435 but not in MCF7 cells. In MDA-MB-435 cells exposed to L-Ann or Dx, no change was observed in the expression of bax, but there was a p53-independent increase in p21waf1 expression. In MCF7 cells, treatment with L-Ann or Dx induced an increase in p53 expression with a consequent transactivation of p21waf1 and bax. Our results indicate that L-Ann is more cytotoxic than Dx in breast cancer cells and is able to induce apoptosis through p53-independent mechanisms.

Original languageEnglish
Pages (from-to)9-22
Number of pages14
JournalJournal of Cellular Biochemistry
Volume81
Issue number1
DOIs
Publication statusPublished - 2001

Fingerprint

Liposomes
Doxorubicin
Cell Cycle
Cells
Apoptosis
Breast Neoplasms
MCF-7 Cells
Cyclin B1
Inhibitory Concentration 50
Phosphotransferases
annamycin
Cell Line
Transcriptional Activation
Therapeutics
Cell Count

Keywords

  • Anthracyclines
  • cdc2 kinase
  • Cell proliferation
  • Flow cytometry
  • p53

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology

Cite this

Effects of liposome-entrapped annamycin in human breast cancer cells : Interference with cell cycle progression and induction of apoptosis. / Orlandi, Linda; Bertoli, Gloria; Abolafio, Gabriella; Daidone, Maria Grazia; Zaffaroni, Nadia.

In: Journal of Cellular Biochemistry, Vol. 81, No. 1, 2001, p. 9-22.

Research output: Contribution to journalArticle

@article{a61fad8e6c5647f39611a456fc18a28c,
title = "Effects of liposome-entrapped annamycin in human breast cancer cells: Interference with cell cycle progression and induction of apoptosis",
abstract = "The effects of liposome-encapsulated annamycin (L-Ann) were investigated in two human breast cancer cell lines, MCF7 and MDA-MB-435. For comparative purposes, doxorubicin (Dx) was used throughout the study. A 4-hour treatment with L-Ann was significantly more active in MDA-MB-435 than in MCF7 cells (IC50 values of 0.03 and 0.08 μg/ml, respectively), whereas Dx was equally active in the two cell lines (IC50 0.12 μg/ml). L-Ann induced an accumulation of cells in G2M phases which was dose-dependent in MDA-MB-435 but not in MCF7 cells. Dx also caused a dose-dependent increase of G2M cell fraction in MDA-MB-435 cells, whereas a G2M cell accumulation was observed only after treatment with the highest Dx concentration in MCF7 cells. G2M phase cell accumulations induced in MCF7 cells by L-Ann or Dx were accompanied by a decrease in cdc2 kinase activity and in cyclin B1 and cdc2 expression. Conversely, in MDA-MB-435 cells exposed to L-Ann or Dx, cdc2 kinase activity, cyclin B1 and cdc2 expression increased in parallel to the increase in the number of cells accumulated in the G2M phase. L-Ann and Dx induced apoptosis in MDA-MB-435 but not in MCF7 cells. In MDA-MB-435 cells exposed to L-Ann or Dx, no change was observed in the expression of bax, but there was a p53-independent increase in p21waf1 expression. In MCF7 cells, treatment with L-Ann or Dx induced an increase in p53 expression with a consequent transactivation of p21waf1 and bax. Our results indicate that L-Ann is more cytotoxic than Dx in breast cancer cells and is able to induce apoptosis through p53-independent mechanisms.",
keywords = "Anthracyclines, cdc2 kinase, Cell proliferation, Flow cytometry, p53",
author = "Linda Orlandi and Gloria Bertoli and Gabriella Abolafio and Daidone, {Maria Grazia} and Nadia Zaffaroni",
year = "2001",
doi = "10.1002/1097-4644(20010401)81:1<9::AID-JCB1020>3.0.CO;2-C",
language = "English",
volume = "81",
pages = "9--22",
journal = "Journal of Cellular Biochemistry",
issn = "0730-2312",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Effects of liposome-entrapped annamycin in human breast cancer cells

T2 - Interference with cell cycle progression and induction of apoptosis

AU - Orlandi, Linda

AU - Bertoli, Gloria

AU - Abolafio, Gabriella

AU - Daidone, Maria Grazia

AU - Zaffaroni, Nadia

PY - 2001

Y1 - 2001

N2 - The effects of liposome-encapsulated annamycin (L-Ann) were investigated in two human breast cancer cell lines, MCF7 and MDA-MB-435. For comparative purposes, doxorubicin (Dx) was used throughout the study. A 4-hour treatment with L-Ann was significantly more active in MDA-MB-435 than in MCF7 cells (IC50 values of 0.03 and 0.08 μg/ml, respectively), whereas Dx was equally active in the two cell lines (IC50 0.12 μg/ml). L-Ann induced an accumulation of cells in G2M phases which was dose-dependent in MDA-MB-435 but not in MCF7 cells. Dx also caused a dose-dependent increase of G2M cell fraction in MDA-MB-435 cells, whereas a G2M cell accumulation was observed only after treatment with the highest Dx concentration in MCF7 cells. G2M phase cell accumulations induced in MCF7 cells by L-Ann or Dx were accompanied by a decrease in cdc2 kinase activity and in cyclin B1 and cdc2 expression. Conversely, in MDA-MB-435 cells exposed to L-Ann or Dx, cdc2 kinase activity, cyclin B1 and cdc2 expression increased in parallel to the increase in the number of cells accumulated in the G2M phase. L-Ann and Dx induced apoptosis in MDA-MB-435 but not in MCF7 cells. In MDA-MB-435 cells exposed to L-Ann or Dx, no change was observed in the expression of bax, but there was a p53-independent increase in p21waf1 expression. In MCF7 cells, treatment with L-Ann or Dx induced an increase in p53 expression with a consequent transactivation of p21waf1 and bax. Our results indicate that L-Ann is more cytotoxic than Dx in breast cancer cells and is able to induce apoptosis through p53-independent mechanisms.

AB - The effects of liposome-encapsulated annamycin (L-Ann) were investigated in two human breast cancer cell lines, MCF7 and MDA-MB-435. For comparative purposes, doxorubicin (Dx) was used throughout the study. A 4-hour treatment with L-Ann was significantly more active in MDA-MB-435 than in MCF7 cells (IC50 values of 0.03 and 0.08 μg/ml, respectively), whereas Dx was equally active in the two cell lines (IC50 0.12 μg/ml). L-Ann induced an accumulation of cells in G2M phases which was dose-dependent in MDA-MB-435 but not in MCF7 cells. Dx also caused a dose-dependent increase of G2M cell fraction in MDA-MB-435 cells, whereas a G2M cell accumulation was observed only after treatment with the highest Dx concentration in MCF7 cells. G2M phase cell accumulations induced in MCF7 cells by L-Ann or Dx were accompanied by a decrease in cdc2 kinase activity and in cyclin B1 and cdc2 expression. Conversely, in MDA-MB-435 cells exposed to L-Ann or Dx, cdc2 kinase activity, cyclin B1 and cdc2 expression increased in parallel to the increase in the number of cells accumulated in the G2M phase. L-Ann and Dx induced apoptosis in MDA-MB-435 but not in MCF7 cells. In MDA-MB-435 cells exposed to L-Ann or Dx, no change was observed in the expression of bax, but there was a p53-independent increase in p21waf1 expression. In MCF7 cells, treatment with L-Ann or Dx induced an increase in p53 expression with a consequent transactivation of p21waf1 and bax. Our results indicate that L-Ann is more cytotoxic than Dx in breast cancer cells and is able to induce apoptosis through p53-independent mechanisms.

KW - Anthracyclines

KW - cdc2 kinase

KW - Cell proliferation

KW - Flow cytometry

KW - p53

UR - http://www.scopus.com/inward/record.url?scp=0035089655&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035089655&partnerID=8YFLogxK

U2 - 10.1002/1097-4644(20010401)81:1<9::AID-JCB1020>3.0.CO;2-C

DO - 10.1002/1097-4644(20010401)81:1<9::AID-JCB1020>3.0.CO;2-C

M3 - Article

VL - 81

SP - 9

EP - 22

JO - Journal of Cellular Biochemistry

JF - Journal of Cellular Biochemistry

SN - 0730-2312

IS - 1

ER -